Effect of Renin-angiotensin System Blockers on Glomerular Filtration Rate in Patients With Hypertension, Type 2 Diabetes With Normoalbuminuria (eGFR)

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2015 by Hospital Authority, Hong Kong
Sponsor:
Information provided by (Responsible Party):
Hospital Authority, Hong Kong
ClinicalTrials.gov Identifier:
NCT01500590
First received: December 23, 2011
Last updated: April 17, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2019
  Estimated Primary Completion Date: August 2018 (Final data collection date for primary outcome measure)